Table 3.

The MLF-index, weigh, and score in producers’ countries in the three periods

	2005–2008				2009–2013				2014–2018
	MLF	*	#	Index	MLF	*	#	Index	MLF	*	#	Index
Argentina	aaa			0	baa	+++	(1)	0.2	aab	+++	(2)	0.2
Brazil	aab	+++	(2)	0.2	aab	+++	(1)	0.2	aab	+++	(1)	0.2
Canada	aaa			0	aab	+++	(1)	0.2	aaa			0
Chile	aaa			0	bbb	++	(1)	0.6	aaa			0
China	cbb	++	(1)	0.8	caa	+++	(3)	0.4	abb	+++	(2)	0.4
Denmark	aaa			0	aaa	+++	(1)	0	aaa			0
France	aaa			0	aab	++	(1)	0.2	aab	++	(1)	0.2
Germany	aab	+++	(1)	0.2	aac	++	(1)	0.4	aaa			0
India	aaa			0	aab	++	(1)	0.2	aaa			0
Italy	aaa			0	aaa	+++	(1)	0	aaa			0
Japan	aaa			0	acc	+++	(2)	0.8	aab	+++	(2)	0.2
Mexico	aaa			0	aac	+++	(2)	0.4	aaa			0
Myanmar	aaa			0	aaa	++	(1)	0	aaa			0
Nederland	aaa			0	aaa			0	aaa			0
Philippines	aaa			0	aaa			0	aaa			0
Poland	aaa			0	aaa			0	abb	+++	(1)	0.4
R. of Korea	aaa			0	acc	+++	(3)	0.8	ccb	+++	(2)	1
Russia	abb	+++	(3)	0.4	bbb	+++	(4)	0.6	ccb	+++	(3)	1
Spain	aaa			0	aaa			0	aaa			0
USA	aaa			0	aaa	+	(1)	0	aaa			0
Viet Nam	cba	++	(1)	0.6	aab	+++	(1)	0.2	aaa			0

MLF-index of diseases assessment in the studied countries. Score index of triad: 0.0 = null, 0.2 = low, 0.4 = medium-low, 0.6 = medium-high, 0.8 = high, and 1.0 = critical effect

^*Semi-quantitative weigh risk of the disease with highest impact: catastrophic (+++), marketable (++), and normal (+) diseases

^#In brackets, the disease number with the indicated weight